Hot Topics

publication

Gilteritinib induces differentiation in relapsed and refractory FLT3-mutated acute myeloid leukemia

An image from this article is featured on the cover of this edition of Blood Advances, a semimonthly medical journal published by the American Society of Hematology.  The cover figure of&

Read more
News

Penn's Gene Therapy Startup Raises Another $50 Million

Funding for cellular therapies that target specific B cells that mediate a wide variety of autoimmune conditions.

Read more
News

National Blood Foundation Early-Career Grant for Dr. Vijay Bhoj

Award for research in the fields of transfusion medicine and cellular therapies.

Read more
News

Stem Cell Lab Part of New Treatment for Lung Complications

Nationwide trial using adult stem cells to battle Acute Respiratory Distress Syndrome.

Read more
News

FDA Approves CAR-T Immunotherapy for 2nd Indication

Approval for a personalized cellular therapy for the treatment of adult patients with relapsed or refractory large B-Cell lymphoma after two or more lines of systemic therapy.

Read more
News

FDA Approval Recommendation for CAR T-Cell Therapy

FDA advisory committee unanimously approves first personalized cellular therapy developed at Penn for pediatric and young adult leukemia.

Read more